Treace Medical to highlight product innovations, data for ALIGN3D, MTA3D

Treace Medical (TMCI) Concepts announced it will highlight new product innovations and present new interim data for the ALIGN3D and MTA3D clinical studies at the American Orthopaedic Foot & Ankle Society, AOFAS, Annual Meeting 2025 in Savannah, Georgia from September 10-13, 2025. “We are excited to highlight the full commercial release of our expanded bunion portfolio at AOFAS, which now provides surgeons with best-in-class solutions to address the entire spectrum of bunion surgery,” said John Treace, CEO, Founder and Chairman of Treace. “With the addition of Nanoplasty, Percuplasty, SpeedMTP, and IntelliGuide PSI, we are building on the success of Lapiplasty and Adductoplasty to advance our Company’s focused mission to improve surgical outcomes for bunion patients. We also look forward to sharing compelling clinical evidence from prospective, multicenter studies that continues to differentiate our flagship Lapiplasty and Adductoplasty procedures.”